• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019冠状病毒病大流行概述。

SARS-CoV-2 pandemic: An overview.

作者信息

Acuti Martellucci Cecilia, Flacco Maria Elena, Cappadona Rosaria, Bravi Francesca, Mantovani Lorenzo, Manzoli Lamberto

机构信息

Section of Hygiene and Preventive Medicine, Department of Biomedical Sciences and Public Health, University of the Marche Region, Via Conca, 60126, Ancona, Italy.

Department of Medical Sciences, University of Ferrara, Via Fossato di Mortara 64/B, 44121, Ferrara, Italy.

出版信息

Adv Biol Regul. 2020 Aug;77:100736. doi: 10.1016/j.jbior.2020.100736. Epub 2020 Jun 17.

DOI:10.1016/j.jbior.2020.100736
PMID:32773099
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7832554/
Abstract

By the end of May 2020, SARS-CoV-2 pandemic caused more than 350,000 deaths worldwide. In the first months, there have been uncertainties on almost any area: infection transmission route, virus origin and persistence in the environment, diagnostic tests, therapeutic approach, high-risk subjects, lethality, and containment policies. We provide an updated summary of the current knowledge on the pandemic, discussing the available evidence on the effectiveness of the adopted mitigation strategies.

摘要

截至2020年5月底,新型冠状病毒肺炎疫情已在全球造成超过35万人死亡。在最初的几个月里,几乎在任何领域都存在不确定性:感染传播途径、病毒起源及在环境中的持久性、诊断检测、治疗方法、高危人群、致死率和防控政策。我们提供了关于该疫情当前知识的最新总结,讨论了所采取缓解策略有效性的现有证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a030/7832554/a28a717d5b99/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a030/7832554/a28a717d5b99/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a030/7832554/a28a717d5b99/gr1_lrg.jpg

相似文献

1
SARS-CoV-2 pandemic: An overview.2019冠状病毒病大流行概述。
Adv Biol Regul. 2020 Aug;77:100736. doi: 10.1016/j.jbior.2020.100736. Epub 2020 Jun 17.
2
Weathering COVID-19 storm: Successful control measures of five Asian countries.应对新冠疫情风暴:五个亚洲国家成功的防控措施。
Am J Infect Control. 2020 Jul;48(7):851-852. doi: 10.1016/j.ajic.2020.04.021. Epub 2020 Apr 29.
3
The principle of distance during COVID-19 outbreak in Korea.韩国 COVID-19 疫情期间的保持距离原则。
Int Microbiol. 2020 Nov;23(4):641-643. doi: 10.1007/s10123-020-00138-w. Epub 2020 Jul 27.
4
Where are we with understanding of COVID-19?我们对新冠病毒的了解处于什么程度?
Adv Biol Regul. 2020 Aug;77:100745. doi: 10.1016/j.jbior.2020.100745. Epub 2020 Jul 21.
5
Epidemiological Investigation of the First 135 COVID-19 Cases in Brunei: Implications for Surveillance, Control, and Travel Restrictions.文莱首例 135 例 COVID-19 病例的流行病学调查:对监测、控制和旅行限制的启示。
Am J Trop Med Hyg. 2020 Oct;103(4):1608-1613. doi: 10.4269/ajtmh.20-0771.
6
COVID-19 in South Korea.韩国的 COVID-19 疫情。
Postgrad Med J. 2020 Jul;96(1137):399-402. doi: 10.1136/postgradmedj-2020-137738. Epub 2020 May 4.
7
Evaluating the Effectiveness of Social Distancing Interventions to Delay or Flatten the Epidemic Curve of Coronavirus Disease.评估社交隔离干预措施在延迟或拉平冠状病毒病流行曲线方面的效果。
Emerg Infect Dis. 2020 Aug;26(8):1740-1748. doi: 10.3201/eid2608.201093. Epub 2020 Apr 28.
8
India's Battle against COVID-19: Progress and Challenges.印度抗击新冠疫情:进展与挑战
Am J Trop Med Hyg. 2020 Oct;103(4):1343-1347. doi: 10.4269/ajtmh.20-0992.
9
Decreased Influenza Incidence under COVID-19 Control Measures, Singapore.新冠防控措施下新加坡流感发病率降低。
Emerg Infect Dis. 2020 Aug;26(8):1933-1935. doi: 10.3201/eid2608.201229. Epub 2020 Apr 27.
10
[Covid-19: how to get prepared for Autumn].[新冠疫情:如何为秋季做准备]
Epidemiol Prev. 2020 Jul-Aug;44(4):201-203. doi: 10.19191/EP20.4.A001.048.

引用本文的文献

1
SARS-CoV-2 RBD Scaffolded by AP205 or TIP60 Nanoparticles and Delivered as mRNA Elicits Robust Neutralizing Antibody Responses.由AP205或TIP60纳米颗粒支架化并作为mRNA递送的SARS-CoV-2 RBD引发强大的中和抗体反应。
Vaccines (Basel). 2025 Jul 22;13(8):778. doi: 10.3390/vaccines13080778.
2
Ferritin Nanocages Exhibit Unique Structural Dynamics When Displaying Surface Protein.铁蛋白纳米笼在展示表面蛋白时呈现出独特的结构动力学。
Int J Mol Sci. 2025 Jul 22;26(15):7047. doi: 10.3390/ijms26157047.
3
PROTAC-Based Antivirals for Respiratory Viruses: A Novel Approach for Targeted Therapy and Vaccine Development.

本文引用的文献

1
Coronavirus Disease 2019: Initial Detection on Chest CT in a Retrospective Multicenter Study of 103 Chinese Patients.2019冠状病毒病:103例中国患者回顾性多中心研究中胸部CT的初步检测
Radiol Cardiothorac Imaging. 2020 Apr 6;2(2):e200092. doi: 10.1148/ryct.2020200092. eCollection 2020 Apr.
2
Severe Acute Respiratory Syndrome Coronavirus 2 Lethality Did not Change Over Time in Two Italian Provinces.严重急性呼吸综合征冠状病毒2在意大利两个省份的致死率并未随时间变化。
Open Forum Infect Dis. 2020 Nov 12;7(12):ofaa556. doi: 10.1093/ofid/ofaa556. eCollection 2020 Dec.
3
Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany.
基于PROTAC的呼吸道病毒抗病毒药物:靶向治疗和疫苗开发的新方法
Microorganisms. 2025 Jul 2;13(7):1557. doi: 10.3390/microorganisms13071557.
4
The Effectiveness of Four Quadrivalent, Inactivated Influenza Vaccines Administered Alone or in Combination with Pneumococcal and/or SARS-CoV-2 Vaccines: A Population-Wide Cohort Study.四种四价灭活流感疫苗单独接种或与肺炎球菌和/或SARS-CoV-2疫苗联合接种的有效性:一项全人群队列研究。
Vaccines (Basel). 2025 Mar 13;13(3):309. doi: 10.3390/vaccines13030309.
5
Development of an intestinal mucosa co-culture model to study viral infections.建立肠道黏膜共培养模型以研究病毒感染。
J Virol. 2024 Oct 22;98(10):e0098724. doi: 10.1128/jvi.00987-24. Epub 2024 Aug 30.
6
Intranasal Administration of Recombinant Newcastle Disease Virus Expressing SARS-CoV-2 Spike Protein Protects hACE2 TG Mice against Lethal SARS-CoV-2 Infection.经鼻给药表达 SARS-CoV-2 刺突蛋白的重组新城疫病毒可保护 hACE2 转基因小鼠免受致死性 SARS-CoV-2 感染。
Vaccines (Basel). 2024 Aug 16;12(8):921. doi: 10.3390/vaccines12080921.
7
Computational design and investigation of the monomeric spike SARS-CoV-2-ferritin nanocage vaccine stability and interactions.新冠病毒刺突蛋白-铁蛋白纳米笼单体疫苗的计算设计、稳定性及相互作用研究
Front Mol Biosci. 2024 Jun 12;11:1403635. doi: 10.3389/fmolb.2024.1403635. eCollection 2024.
8
Attitude toward vaccination against COVID-19 and acceptance of the national "QazVac" vaccine in the Aktobe city population, West Kazakhstan: A cross-sectional survey.对 COVID-19 疫苗接种的态度以及对哈萨克斯坦西部阿克托贝市人口中“QazVac”国家疫苗的接受度:一项横断面调查。
PLoS One. 2024 May 16;19(5):e0303854. doi: 10.1371/journal.pone.0303854. eCollection 2024.
9
Effectiveness of tailored talks between a cancer screening specialist and general practitioners to improve the uptake of colorectal cancer screening in Ancona (Italy) during the pandemic period.在大流行期间,癌症筛查专家与全科医生之间进行针对性谈话以提高意大利安科纳地区结直肠癌筛查接受率的有效性。
Eur J Gen Pract. 2024 Dec;30(1):2340672. doi: 10.1080/13814788.2024.2340672. Epub 2024 Apr 15.
10
Psychological impact of COVID-19 and determinants among Spanish university students.COVID-19 对西班牙大学生的心理影响及其决定因素。
Front Public Health. 2023 Oct 18;11:1252849. doi: 10.3389/fpubh.2023.1252849. eCollection 2023.
德国超级传播事件中 SARS-CoV2 的感染病死率。
Nat Commun. 2020 Nov 17;11(1):5829. doi: 10.1038/s41467-020-19509-y.
4
The Relationship of COVID-19 Severity with Cardiovascular Disease and Its Traditional Risk Factors: A Systematic Review and Meta-Analysis.新型冠状病毒病严重程度与心血管疾病及其传统危险因素的关系:系统评价和荟萃分析。
Glob Heart. 2020 Sep 22;15(1):64. doi: 10.5334/gh.814.
5
Indoor transmission of SARS-CoV-2.室内传播的 SARS-CoV-2。
Indoor Air. 2021 May;31(3):639-645. doi: 10.1111/ina.12766. Epub 2020 Nov 20.
6
A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates.对已发表的关于 COVID-19 感染病死率的研究数据的系统回顾和荟萃分析。
Int J Infect Dis. 2020 Dec;101:138-148. doi: 10.1016/j.ijid.2020.09.1464. Epub 2020 Sep 29.
7
Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19).血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂的使用与新型冠状病毒病 2019(COVID-19)检测阳性的关联。
JAMA Cardiol. 2020 Sep 1;5(9):1020-1026. doi: 10.1001/jamacardio.2020.1855.
8
Inferred duration of infectious period of SARS-CoV-2: rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 cases.推断 SARS-CoV-2 的传染期:对无症状和有症状 COVID-19 病例的现有证据进行快速范围审查和分析。
BMJ Open. 2020 Aug 5;10(8):e039856. doi: 10.1136/bmjopen-2020-039856.
9
Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens.预测感染意大利公民中严重或致命的 COVID-19 的因素,包括血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂。
PLoS One. 2020 Jun 24;15(6):e0235248. doi: 10.1371/journal.pone.0235248. eCollection 2020.
10
SARS-CoV-2 infection of the placenta.SARS-CoV-2 感染胎盘。
J Clin Invest. 2020 Sep 1;130(9):4947-4953. doi: 10.1172/JCI139569.